SEC Form 4 · accession 0001387131-18-002525
Corindus Vascular Robotics, Inc. · CVRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark J Toland
Officer — President and CEO · Director
Period of report
May 31, 2018
Accepted (ET)
Jun 4, 2018 · 6:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528557
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified stock option (right to buy)F1 | $0.7501 | May 31, 2018 | A | 5,183,322 | A | — | May 31, 2028 | Common Stock | 5,183,322 | 5,183,322 | D |
Explanation of responses
- F1The option shall vest on the date of certification by the Compensation Committee of the Board of the achievement of the following milestones, provided Mr. Toland is providing services to the Company or its affiliates on the date of such achievement: 25% of the option shall vest if the closing price of the Company's Common Stock meets or exceeds each of $2.15, $3.00, $3.85 and $4.75, respectively, for a period of at least twenty consecutive trading days at any time before May 31, 2021.